Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06185296 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

The Intelligent Diabetes TelemonitoRing Using Decision Support to Treat Patients on Insulin Therapy

Study acronym: DiaTRUST
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated February 9, 2026 (before its estimated September 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruitingv6 Show 5 more changesShow less
    • Start date changed from estimate of May 2025 to Nov 15, 2025
    • Primary and study completion dates: Jun 2026 to Sep 2026
    • Secondary endpoints: 29 to 20
    • Study description revised
    • Site details revised
  2. Primary and study completion dates: Jun 2025 to Jun 2026
    • Start date: Oct 2024 to May 2025
    v5
  3. Start date: May 2024 to Oct 2024v4
  4. Primary and study completion dates: Mar 2024 to Jun 2025
    • Start date: Mar 2024 to May 2024
    v3
  5. Secondary endpoints: details revised at 1 of 29 entriesv2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The trial is an open-label, randomized controlled trial. Patients with T2D on insulin therapy will be randomized to an intelligent telemonitoring group (intervention), a telemonitoring group (control), and a usual care group (control). Both the intelligent telemonitoring group and the telemonitoring group will use various devices at home. Hospital staff will monitor their data for three months. In the intelligent telemonitoring group, hospital staff and participants will be supported by decision-support algorithms in the management of insulin treatment.
Trial Details
NCT Number NCT06185296
Lead Sponsor Aalborg University Hospital
Collaborators: Novo Nordisk A/S, DexCom, Inc.
Conditions
(from sponsor)		 Type 2 Diabetes Treated With Insulin
Related terms Diabetes Mellitus, Insulin Resistance
Enrollment 51 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov